Eris Biotech logo

Eris BiotechOur drugs engage the immune system to fight tumors

We are developing cancer therapeutics using small molecules that inhibit immune suppression. Our drugs engage the immune system to aggressively fight tumors. In addition, our drugs have a unique delivery mechanism known as hypoxia-activated prodrugs (HAPs). HAPs are drugs designed to become active in a hypoxic (low oxygen) environment, which is a hallmark of the majority of solid tumors. By delivering active drugs only to the tumor site, we hope to overcome systemic toxicity in cancer therapeutics. Our therapeutic portfolio addresses a range of solid tumors, starting with mesothelioma.

2024-01-26
Active
Early
W24
2
Healthcare
United States of AmericaAmerica / Canada
Eris Biotech screenshot
More About Eris Biotech

Eris Biotech - Striking Cancer Where it Lives

Introduction

At Eris Biotech, we're pioneering a revolution in cancer care. Our innovative treatments specifically target the tumor microenvironment, ensuring maximum effectiveness with minimal side effects. We're not just developing medicine, we're crafting hope. Join us in shaping a healthier future.

Key Features

  • Targeted cancer treatments
  • Minimal side effects
  • Innovative tumor microenvironment focus
  • Cutting-edge research and development
  • Patient-centric approach

Use Cases

  • Treatment of various cancer types
  • Personalized cancer therapy
  • Enhancing existing cancer treatment protocols
  • Reducing side effects in cancer treatment
  • Improving patient quality of life

Pricing

Our pricing model is designed to be accessible and transparent. We offer various plans tailored to meet the needs of different patients and healthcare providers. Contact us for detailed pricing information and to find the plan that best suits your needs.

Teams

Our team at Eris Biotech is composed of leading scientists, researchers, and healthcare professionals dedicated to advancing cancer treatment. We work collaboratively to push the boundaries of what's possible in cancer care, ensuring that our innovations translate into real-world benefits for patients.